Updated Moelis report has the TP at $2.40 I think one one of the issues is that they're very slow to acquire centres seemingly solely relying on centres from the incubator.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025